Department of Medicine, Vanderbilt School of Medicine, Vanderbilt Hospital, Nashville, TN, USA.
Cardiol Rev. 2009 Nov-Dec;17(6):275-9. doi: 10.1097/CRD.0b013e3181bc23d1.
Lifestyle modifications and pharmacologic therapy have been the mainstays of treatment for patients with type 2 diabetes mellitus. Bariatric surgery, originally designed as a weight loss treatment, has been proven to ameliorate and even cure diabetes. The significant improvement in glycemic control found after bariatric surgery in patients with diabetes often precedes major weight loss. Therefore, a weight-independent mechanism has been thought to initiate this amelioration in glucose control. Reviews of the recent literature question the goal of bariatric surgery, not only to treat obesity through restriction and malabsorption, but also as a possible treatment for diabetes regardless of the degree of obesity. Procedures such as Roux-en-Y gastric bypass, adjustable gastric banding, and biliopancreatic diversion have proven to be extremely effective in controlling diabetes mellitus. Mechanisms explaining the effectiveness of weight reduction surgery include effects on incretins, ghrelin secretion, and insulin sensitivity. Some centers have been performing gastric bypass surgeries on patients with a lower body mass index than that recommended by current NIH guidelines. New considerations for recommending bypass surgery are warranted as the indications for antiobesity surgeries grow to encompass both the treatment and cure of diabetes.
生活方式改变和药物治疗一直是 2 型糖尿病患者的主要治疗方法。减重手术最初是作为一种减肥治疗方法而设计的,现已被证明可以改善甚至治愈糖尿病。糖尿病患者在接受减重手术后血糖控制得到显著改善,往往早于体重的大幅减轻。因此,人们认为有一种与体重无关的机制启动了这种血糖控制的改善。最近的文献综述对减重手术的目标提出了质疑,不仅要通过限制和吸收不良来治疗肥胖,还要将其作为一种治疗糖尿病的方法,而不论肥胖程度如何。Roux-en-Y 胃旁路术、可调胃束带术和胆胰分流术等手术已被证明对控制糖尿病非常有效。解释减重手术有效性的机制包括对肠促胰岛素、胃饥饿素分泌和胰岛素敏感性的影响。一些中心对体重指数低于美国国立卫生研究院(NIH)现行指南推荐水平的患者进行胃旁路手术。随着肥胖症手术适应证扩大到糖尿病的治疗和治愈,有必要对旁路手术的适应证提出新的考虑。